| Date | Issuer | Type | Security | Price | Units | Value | |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc. | A | Common Stock, par value $0.0001 per share | |||||
| Corbus Pharmaceuticals Holdings Inc. | A | Stock options (right to buy) | |||||
| ArriVent BioPharma Inc. Chief Financial Officer | A | Stock Option (right to buy) | |||||
| Janux Therapeutics Inc. | A | Common Stock | |||||
| Janux Therapeutics Inc. | A | Stock Option (right to buy) |